Decentralizing HIV Care from Specialty Clinics to Primary Centers in Peru
Official title: Innovations in Implementing Decentralized HIV Services in Peru
Funded at Yale University · NIH-11552148 · Data updated 2026-11-12
Aimed at making HIV care more convenient and consistent by moving services from big clinics to local primary care centers in Peru, with lessons that could also help the U.S. healthcare system.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | July 6, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $174,178 |
| NIH project number | 3R01AI177082-04S1 |
| Project ID | NIH-11552148 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV who are clinically stable and eligible for care in primary healthcare centers in Peru, particularly those facing travel, time, or stigma barriers.
✕Less likely to help
Patients requiring intensive specialty services or those not yet ready for transfer to primary care.
What this research studies
This project tests a practical approach to shift stable HIV care from specialized clinics to community primary care settings using a hub-and-spoke model. It will apply NIATx workflow redesign and Project ECHO clinical mentoring to guide and support primary centers. The study will measure how well this decentralization works in real-world Peru settings and examine safety, viral suppression, and retention in care. Results will help determine if similar strategies could ease patient burdens and improve long-term outcomes in diverse healthcare systems, including the United States.
Why it matters
Potential benefit: If successful, patients could access HIV care closer to home with better retention and viral suppression.
How similar studies have gone: Previous implementation efforts in similar settings suggest that decentralized care can improve access, with mixed results depending on context.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Altice, Frederick Lewis — Yale University
- Study coordinator: Altice, Frederick Lewis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.